TSE •
Healthcare •
Biotechnology •
Quote as of 09/18/2026 15:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization57,541 mln
Float9.49 mln
Earnings Date06/12/2025
EPS
8.23
Stretched
P / E
323
Bubble territory
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
14.92
Highly suspicious
Relative Strength
99
/ 100
Top performer
Pre-Tax Margin
-70%
Severely loss-making
Business Description
Heartseed Inc. is a Tokyo-based biotechnology company founded in 2015 that uses stem cell technology to develop treatments for heart failure. Its main focus is creating replacement heart muscle cells grown from reprogrammed human cells, with its lead therapy targeting patients whose hearts cannot pump blood effectively due to conditions like dilated cardiomyopathy. The company has also built a range of supporting technologies to produce and refine these cell-based treatments at scale.
